Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions

Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

Unlock Medical Device Reimbursement & Market Access

Our medical device reimbursement & market access consultants compress the launch-to-coverage cycle so your innovation wins payment, policy, and revenue faster.

The Medical Device Reimbursement - Access Challenge

Even an FDA-cleared device stalls if its medical device reimbursement strategy misses payer and purchaser priorities. You may need a new CPT code, a realistic payment benchmark, and a value-driven policy pitch to land in lock-step. Miss one and you risk 18–24 months of lost revenue while competitors surge ahead.
reim-model-2

Securing market access requires more than clinical data; it demands compelling economic evidence that wins payers over. 

We sync every move with your Integrated Evidence Plan, delivering the 'Evidence ROI' that moves stakeholders from assessment to adoption.

Our Integrated Reimbursement & Market Access Loop

Strategy and execution under one roof and synchronized with your Integrated Evidence Plan

A seamless launch demands more than isolated tactics.  It needs a loop where coding, payment, and coverage feed and speed each other. By running every step through one integrated team, we capture real-time payer feedback, plug economic evidence in at the right moment, and keep the whole machine turning until full reimbursement is locked. 
Phase What we deliver Your advantage

Coding Strategy

CPT/HCPCS mapping, NTAP & DRG alignment.

First-time code success with no costly resubmits.

Payment Benchmarking

Price corridors, revenue-impact models.

Launch with defensible ASPs.

Coverage Engagement

Payer dossiers, KOL letters, live advisory boards.

Faster positive policy decisions.

Global Market-Access Roadmaps

NA, EU, APAC, LATAM sequencing with local HTA / Payer input.

One plan, multi-region reach.

Related Articles

Latest Blog Entries

Services Overview

Medical Device Reimbursement & Market Access Capabilities 

Partnering with Veranex gives you one integrated squad that codes, models, consults and collaborates across disciplines under the same roof.  Distill and refine your reimbursement and market access strategy with our experts. In addition, as an Innovation CRO, we can sync every move with your Integrated Evidence Plan and product-design sprints—so surprises vanish, payment decisions land faster, and your launch stays on budget and ahead of schedule.
reim-1

Medical Device Reimbursement Strategy

01

Medical Device Reimbursement Strategy

Map codes, payment rates, and evidence gaps into a phased roadmap—reinforced by economic proof from our HEOR consulting team.

Learn more

reim-2

Market-Access Readiness Assessment

02

Market-Access Readiness Assessment

Score coding, payment, and coverage status; leave with a 90-day action plan.

reim-3

Payer Advisory Panels

03

Payer Advisory Panels

Pressure-test your value story with top US & EU payers in < 2 weeks.

reim-4

Global Launch Playbooks

04

Global Launch Playbooks

Sequence country launches around reimbursement feasibility and payer evidence expectations, using demand data from our Market Research & Insights.

Learn more

The Team Driving your Market Access Strategy Forward

Our strategists have decades of experience demonstrating value to the payers, providers, and health systems that determine your success.
tim-sheflin

Tim Sheflin

Vice President, Commercial Strategy and Market Access
kp

Catheline Plaideau, PhD 

Director, Product Commercialization
david-s

David Schmidt, PhD 

Sr Manager, Product Commercialization

From Strategy to Success: Medical Device Reimbursement in Action 

Explore how we translate reimbursement strategy into real-world coverage and revenue for our clients. 

reim-case-1

Remote Cardiac Rehabilitation — Market Access Assessment 

 

Situation

A top device maker developing the first virtual cardiac-rehab program needed to map coverage, coding, and reimbursement pathways for a care-at-home model that would replace in-clinic rehab. 

Successes

  • Profiled current coverage and evidence requirements for remote rehab
  • Captured payer + IDN views on adoption and evidence thresholds
  • Delivered strategic recommendations to refine the program and engage stakeholders for optimal market access

 

Services by Veranex

  • Reimbursement Assessment & Strategy
  • Evidence & Market-Access Roadmap
  • Coding & Claims-Data Analysis

reim-case-2

Ambulatory Heart-Failure Monitor — Market Access & Pricing Strategy 

 

Situation

A device manufacturer sought payer insight and physician-adoption drivers to launch a novel ambulatory fluid-monitoring device for heart-failure patients.

Successes

  • Mapped standard of care and emerging trends in ambulatory cardiac monitoring
  • Defined payer evidence thresholds and study designs needed for coverage
  • Identified price-sensitivity breakpoints and co-insurance impact on utilization
  • Outlined implementation tactics for payer engagement and evidence development

 

Services by Veranex

  • Reimbursement Assessment & Strategy
  • Evidence & Market-Access Roadmap
  • Pricing Strategy
  • Coding & Claims-Data Analysis
  • Payer Advisory Board & Consensus Panel

Discover More

Related Services at Veranex

Integrated Evidence Planning (IEP)

Integrated Evidence Planning (IEP)

Plan studies that power reimbursement from day one.

Learn more

Integrated_Evidence_Planning_500x500

HEOR Strategy & Consulting

HEOR Strategy & Consulting

Economic models & RWE that win payers.

Learn more

Health Economics and Outcomes Research_500x500

Market Research & Insights

Market Research & Insights

Size demand and price right before launch.

Learn more

Market Insights

Product Design & Development

Product Design & Development

Craft concept-to-prototype solutions that speed regulatory success and wow users from first touchpoint.

Learn more

Design and Development_500x500

Ready to Accelerate Your Medical Device Market Access?

A successful launch hinges on a flawless market access strategy. Our integrated team delivers the coding, payment, and coverage roadmap that eliminates costly delays and turns your reimbursement plan into your revenue plan. Connect with our experts to secure your product’s place in the market.

Contact us